5 Stocks Under $10 Set to Soar Higher
Just take a look at some of the hot movers in the under-$10 complex from Wednesday, including China Precision Steel (CPSL) , which skyrocketed higher by 44%; Genetic Technologies (GENE) , which soared by 25%; Empire Resorts (NYNY) , which trended up 18%; and BSD Medical (BSDM) , which closed up 15.3%. You don't even have to catch the entire move in lower-priced stocks such as these to make outsized returns when trading.
One low-priced stock that I recently flagged that went on to soar higher was Repligen (RGEN) . On Aug. 16, I highlighted RGEN at around $4.70 a share . I liked the way that RGEN was coiling up in a tight trading pattern as it moved within range of triggering a near-term breakout trade . I also liked that there was a previous gap that could get filled quickly if RGEN did break out.
Guess what happened? Shares of RGEN did trigger that breakout with decent volume, and the stock went on to hit a recent high of $5.86 a share. Shares of RGEN still look technically bullish and poised for higher prices. The next major breakout will trigger once RGEN takes out $5.86 with volume. If we get that action, this stock could easily tag its April high of $7.29 a share. Some near-term support sits at $5.25 a share.
I'm not as eager to recommend investing long term in stocks that trade less than $10 a share because these names can be very speculative, and the odds for picking the long-term winners aren't great. But I definitely love to trade stocks that are priced below $10. I like to view them as a trading vehicle with lots of volatility and lots of upside when the trade is timed right.
When I trade under-$10 names, I do it almost entirely based off of the charts and technical analysis. I also like to find under-$10 names with a catalyst, but that's secondary to the chart and volume patterns.
With that in mind, here's a look at several under-$10 stocks that look poised to potentially trade higher from current levels.
One under-$10 stock in the biotechnology and drugs complex that's trading very close to triggering a breakout trade is Dara Biosciences (DARA) , a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care pharmaceutical products. This stock has been hit hard by the bears during the last six months, with shares down by over 50%.